Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more) Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Also a question of the bullboard's motive
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(800)
•••
Comment by SouthernTierTomon May 26, 2022 8:04pm
109 Views
Post# 34710772

RE:Also a question of the bullboard's motive

RE:Also a question of the bullboard's motiveIt will be interesting..."INdeed"

History dictates this type of a bullboard story in the mid 50's ( leading to a 30 cent financing in 2019 ) and more recently in the mid 40's, leading to where we are now.

Sometimes great stories provide even greater wealth opportunities..."Time creates the need to finance, and financing can create wealth"

I'm sure this is indeed as wonderful as ALL the bullboard elves claim it to be and as wonderful as the elves claim "one another to be"

I would proceed wisely..just my 2 cents ( albeit USD )..as you should, this is a "speculative Canadien Bio" ... dreams of a 2B to 10B valuation as advertised here will indeed require some work first..the company is currently valued in the 50M range.  That is much less than the frequently "bullboard adverstised" 2B to 10B range..."Pay attention"

GLTA,
Thomas
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities